野村 弘行

Nomura Hiroyuki

  • 教授
  • 学位:博士(医学)

基本情報

所属

  • Undergraduate School of Medicine / Faculty of Medicine

詳細情報

研究キーワード

  • Obstetrics and Gynecology
  • Gynecologic oncology
  • Clinical oncology
  • Biomarker

研究分野

  • Life sciences Obstetrics and gynecology Gynecologic oncology

論文

Clinicopathological Status and Prognostic Factors of Recurrent Epithelial Ovarian Cancer in Japan: Retrospective Survey of JSOG Committee on Gynecologic Oncology.

Clinical utility of the Geriatric-8 in the functional assessment of patients with gynecological cancer aged 75 and older: a retrospective study.

Neoadjuvant chemotherapy with interval debulking surgery in elderly women with advanced ovarian, fallopian tube, or primary peritoneal cancer: real-world evidence from japan

Impact of neoadjuvant chemotherapy followed by interval debulking surgery on survival in women with advanced non-serous ovarian, fallopian tube, or primary peritoneal cancer.

Ovarian metastases from renal cell carcinoma: A report of two cases.

A retrospective study on hormone replacement therapy after ovarian cancer surgery at our hospital.

Minimally invasive primary staging surgery for early-stage ovarian cancer: A systematic review and meta-analysis

The impact of public insurance on RRSO for HBOC in Japan: a nationwide data study.

Prognostic significance of para-aortic node metastasis in endometrial cancer: Japanese Gynecologic Oncology Group Study JGOG2043 post hoc analysis

Efficacy and safety of minimally invasive surgery versus open laparotomy for epithelial ovarian cancer: A systematic review and meta-analysis.

Prognostic impact of the number of resected pelvic nodes in endometrial cancer: Japanese Gynecologic Oncology Group Study JGOG2043 post hoc analysis.

Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2.

Initial experience and surgical outcomes of robotic-assisted total hysterectomy using the da Vinci SP surgical system.

A first-in-human phase I study of TAS-117, an allosteric AKT inhibitor, in patients with advanced solid tumors.

A prospective clinical trial of diathermy ablation for patients with high-grade cervical intraepithelial neoplasia from a single institution in Japan

Pretreatment systemic inflammatory markers predict survival in endometrial cancer: A Japanese Gynecologic Oncology Group 2043 exploratory data analysis

書籍等出版物

  • Cell Biology of the Ovary
  • Frontiers in Ovarian Cancer Science
  • 各論16 卵巣癌 分子腫瘍マーカー診療ガイドライン第1版
  • 卵巣がん プラチナ抵抗性再発 ノギテカン1.25-1.5±ベバシズマブ療法
  • 卵巣がん プラチナ抵抗性再発 経口エトポシド療法
  • 卵巣がん治療ガイドライン 2015年版(第4版)
  • プロメテウス 婦人科がん最新医療
  • プロメテウス 婦人科がん最新医療
  • Epigenetics in Human Disease
  • CANCER OF THE UTERINE ENDOMETRIUM - ADVANCES AND CONTROVERSIES
  • 婦人科がん 低侵襲手術
  • Repair and Human Health
  • 産婦人科学レビュー2011 -最新主要文献と解説-
  • ワシントンがん診療マニュアル
  • ワシントンがん診療マニュアル
  • Chemotherapeutic Strategies for Gynecological Cancers
  • 婦人科癌化学療法ポケットマニュアル
  • 遺伝子医学MOOK11 臨床糖鎖バイオマーカーの開発-糖鎖機能の解明とその応用
  • 産婦人科 専門医にきく最新の臨床
  • 産婦人科 専門医にきく最新の臨床

講演・口頭発表等

  • 若年子宮体癌/子宮内膜異型増殖症に対する高用量黄体ホルモン療法の再発例の検討
  • 腫瘍学的視点から見た卵巣腫瘍診断における超音波検査の意義
  • Clinicopathological background and prognosis of advanced ovarian cancer patients without optimal cytoreduction at primary surgery
  • Recent topics of clinical trials on endometrial cancer in Japan
  • Correlation between the relative dose intensity of paclitaxel plus carboplatin therapy and clinical background factors in patients with ovarian cancer
  • HBOCサーベイランスとRRSOについて
  • 腹腔鏡下子宮全摘出術における腟断端および腹膜縫合の際の有棘縫合糸の使用経験
  • Efficacy and safety of nivolumab in patients with uterine cervical or corpus cancers or soft tissue sarcoma - A phase II trial
  • 子宮体癌に対して拡大術式および系統的リンパ節郭清を推奨しない立場から
  • 異型ポリープ状腺筋腫に対し高用量黄体ホルモン療法を行った22例の検討
  • 婦人科腫瘍専門医からみた卵巣腫瘍の超音波診断の意義と問題点
  • 卵巣癌術前化学療法(NAC)奏効不良例の体腔液細胞診所見と臨床的背景の検討
  • 卵巣癌化学療法の個別化を目指した腫瘍組織由来および腹水中細胞を用いた初代3次元培養法の確立
  • Efficacy and safety of nivolumab in patients with advanced or recurrent uterine cervical or corpus cancers
  • GSTP1 rs1695 is a predictive indicator of both hematological toxicity and prognosis of ovarian cancer treated with paclitaxel plus carboplatin
  • 本邦における高齢婦人科悪性腫瘍に対する治療の実態を明らかにするためのアンケート調査:Japan Clinical Oncology Group (JCOG)婦人科腫瘍グループ
  • 有害事象によりベバシズマブ投与を中止した婦人科がん症例の検討
  • The recent novel findings in adjuvant chemotherapy for endometrial cancer
  • 日本を代表する臨床試験 JGOG -本邦における子宮体がん臨床試験の流れを中心に-
  • 【化学療法総論】婦人科腫瘍医のためのがん薬物療法総論

担当経験のある科目

  • Gynecology
  • Clinical pathology
  • Clinical Pathophysiology
  • Gynecology
  • Female reproductive system
  • Gynecologic oncology

所属学会

  • JAPAN SOCIETY OF OBSTETRICS AND GYNECOLOGY
  • 日本臨床細胞学会
  • Japan Society of Endoscopy and Robotics in Gynecology and Obstetrics
  • JAPAN SOCIETY OF CLINICAL ONCOLOGY
  • International Gynecologic Cancer Society
  • THE JAPAN SOCIETY FOR MENOPAUSE AND WOMEN'S HEALTH
  • THE JAPAN SOCIETY OF HUMAN GENETICS
  • THE JAPANESE CANCER ASSOCIATION

Works(作品等)

第16回臨床研修指導医養成ワークショップ修了

第18回共用試験医学系OSCE評価者認定講習会修了(医療面接)

がん診療に携わる医師のための緩和ケア研修会修了

第25回内視鏡下結紮・縫合手技講習会修了

共同研究・競争的資金等の研究課題

Exploring a novel treatment and related biomarkers for advanced/recurrent ovarian cancer

Search for drug resistance genes in ovarian cancer cells by new exhaustive genome screening method

Alteration of tumor immunity and anti-cancer drug / hormone sensitivity in endometrial cancer with frequent MMR mechanism abnormality

An individual diagnosis of uterine cancer stem cells by SNP analysis

Exploration of endometrial cancer-associated microRNAs by using a functional screening method and its application to medication

The explication of the role of carbohydrates in peritoneal metastasis of ovarian cancer

ResearchMapへ移動します

Contact Us

Inquiries about coverage

Public Affairs Division Public Affairs and Communications Department

Tel. 0463-63-4670(direct dialing)